Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Skidmore

Showing results (121-130 of 133) with videos related to

Pageof 14
Sort By:
RSC Chemical Biology|August 2, 2024
Correction: Virtual screening, identification and <i>in vitro</i> validation of small molecule GDP-mannose dehydrogenase inhibitorsJonathan P Dolan, Sanaz Ahmadipour, Alice J C Wahart, et al.
Carbohydrate Research|January 30, 2008
Site-specific interactions of copper(II) ions with heparin revealed with complementary (SRCD, NMR, FTIR and EPR) spectroscopic techniquesT R Rudd, M A Skidmore, S E Guimond, et al.
Biochemistry|April 30, 2009
Cations modulate polysaccharide structure to determine FGF-FGFR signaling: a comparison of signaling and inhibitory polysaccharide interactions with FGF-1 in solutionScott E Guimond, Timothy R Rudd, Mark A Skidmore, et al.
Organic & Biomolecular Chemistry|September 25, 2010
Comparable stabilisation, structural changes and activities can be induced in FGF by a variety of HS and non-GAG analogues: implications for sequence-activity relationshipsTimothy R Rudd, Katarzyna A Uniewicz, Alessandro Ori, et al.
Journal of Neurosurgery. Spine|December 21, 2006
Quality of life of lumbar stenosis-treated patients in whom the X STOP interspinous device was implantedKen Y Hsu, James F Zucherman, Charles A Hartjen, et al.
European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|December 20, 2003
A prospective randomized multi-center study for the treatment of lumbar spinal stenosis with the X STOP interspinous implant: 1-year resultsJ F Zucherman, K Y Hsu, C A Hartjen, et al.
Spine|June 17, 2005
A multicenter, prospective, randomized trial evaluating the X STOP interspinous process decompression system for the treatment of neurogenic intermittent claudication: two-year follow-up resultsJames F Zucherman, Ken Y Hsu, Charles A Hartjen, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|September 22, 2022
Evidence for Multiple Binding Modes in the Initial Contact Between SARS-CoV-2 Spike S1 Protein and Cell Surface GlycansMichela Parafioriti, Minghong Ni, Maurice Petitou, et al.
Frontiers in Pharmacology|August 23, 2021
The Hyperlipidaemic Drug Fenofibrate Significantly Reduces Infection by SARS-CoV-2 in Cell Culture ModelsScott P Davies, Courtney J Mycroft-West, Isabel Pagani, et al.
Computational and Structural Biotechnology Journal|May 10, 2021
Evidence of a putative glycosaminoglycan binding site on the glycosylated SARS-CoV-2 spike protein N-terminal domainZachariah P Schuurs, Edward Hammond, Stefano Elli, et al.
Pageof 14

Showing results (121-130 of 133) with videos related to

Sort By:
Pageof 14
RSC Chemical Biology|August 2, 2024
Correction: Virtual screening, identification and <i>in vitro</i> validation of small molecule GDP-mannose dehydrogenase inhibitorsJonathan P Dolan, Sanaz Ahmadipour, Alice J C Wahart, et al.
Carbohydrate Research|January 30, 2008
Site-specific interactions of copper(II) ions with heparin revealed with complementary (SRCD, NMR, FTIR and EPR) spectroscopic techniquesT R Rudd, M A Skidmore, S E Guimond, et al.
Biochemistry|April 30, 2009
Cations modulate polysaccharide structure to determine FGF-FGFR signaling: a comparison of signaling and inhibitory polysaccharide interactions with FGF-1 in solutionScott E Guimond, Timothy R Rudd, Mark A Skidmore, et al.
Organic & Biomolecular Chemistry|September 25, 2010
Comparable stabilisation, structural changes and activities can be induced in FGF by a variety of HS and non-GAG analogues: implications for sequence-activity relationshipsTimothy R Rudd, Katarzyna A Uniewicz, Alessandro Ori, et al.
Journal of Neurosurgery. Spine|December 21, 2006
Quality of life of lumbar stenosis-treated patients in whom the X STOP interspinous device was implantedKen Y Hsu, James F Zucherman, Charles A Hartjen, et al.
European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|December 20, 2003
A prospective randomized multi-center study for the treatment of lumbar spinal stenosis with the X STOP interspinous implant: 1-year resultsJ F Zucherman, K Y Hsu, C A Hartjen, et al.
Spine|June 17, 2005
A multicenter, prospective, randomized trial evaluating the X STOP interspinous process decompression system for the treatment of neurogenic intermittent claudication: two-year follow-up resultsJames F Zucherman, Ken Y Hsu, Charles A Hartjen, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|September 22, 2022
Evidence for Multiple Binding Modes in the Initial Contact Between SARS-CoV-2 Spike S1 Protein and Cell Surface GlycansMichela Parafioriti, Minghong Ni, Maurice Petitou, et al.
Frontiers in Pharmacology|August 23, 2021
The Hyperlipidaemic Drug Fenofibrate Significantly Reduces Infection by SARS-CoV-2 in Cell Culture ModelsScott P Davies, Courtney J Mycroft-West, Isabel Pagani, et al.
Computational and Structural Biotechnology Journal|May 10, 2021
Evidence of a putative glycosaminoglycan binding site on the glycosylated SARS-CoV-2 spike protein N-terminal domainZachariah P Schuurs, Edward Hammond, Stefano Elli, et al.
Pageof 14